Quadpack manufacturing partner Yonwoo has recently been awarded ISO 15378:2011 certification. This standard relates to the design, manufacture and supply of primary packaging materials for medicinal products.

The certification is the first step in Yonwoo's plans to break into the pharmaceutical packaging market.

The global pharmaceutical market is currently worth $942 billion, with a packaging spend of around $3.9 billion on plastic primary packaging*. Moreover, Yonwoo's airless portfolio lends itself particularly well to this sector, making it a natural target for the company.

Yonwoo patented airless technology protects formulas from oxygen, gas and external contaminants. Its check valve system further prevents seep-back, making it very appropriate for delicate, complex formulas.

"We have numerous packaging concepts with a clinical design", comments Yonwoo marketing manager Kevin Parks. "Our airless syringe, our Ampoule Program and our Qure OTC pack are all designed with cosmeceutical treatments in mind. We are now preparing to take the next step into the pharmaceutical market, which has its own set strict regulations."

To conform to these regulations, Yonwoo plans to construct a purpose-built factory dedicated to the production of packaging for medicines, within the next three years.

Quadpack CEO Tim Eaves applauds Yonwoo's strategic plans:

"The pharmaceutical sector has huge potential for a company of Yonwoo's calibre, with a robust R&D operation and a solid track record in technological innovation. We are ready and eager to support Yonwoo as its plans come to fruition."

 

*Source: Euromonitor